Screener
Nuvation Bio NUVB Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's total equity?
- Nuvation Bio (NUVB) reported total equity of $253.86M in Q2 2026.
- How has Nuvation Bio's total equity changed year-over-year?
- Nuvation Bio's total equity decreased by 31.9% year-over-year, from $372.91M to $253.86M.
- What is the long-term trend for Nuvation Bio's total equity?
- Over 5 years (2020 to 2025), Nuvation Bio's total equity has grown at a 7.3% compound annual growth rate (CAGR), from $215.08M to $305.72M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Nuvation Bio's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude